Organic sulphur derivatives;Dérivés organiques soufrés

EMC - Toxicologie-Pathologie

Volumn 2, Issue 4, 2005, Pages 151-162

  Cezard C ^a   Mathieu Nolf, M ^a  

^a Centre Hospitalier Régional de Lille   (France)

Author keywords

Benzothiazoles; Mercaptans; Organic derivatives of the sulphur; Sulphates; Sulphides; Sulphones; Sulphoxides; Thiols; Thioureas

Indexed keywords

ANIMALIA;

EID: 32644449031     PISSN: 17625858     EISSN: 17625858     Source Type: Journal    
DOI: 10.1016/j.emctp.2005.08.001     Document Type: Short Survey

References (132)

1. Clayton GD, Clayton FE. Patty's industrial hygiene and toxicology. New York: Wiley and sons; 1993 (5045p).
2. Davis DJ, Davis JA, Christianson GT, Firefighter's hazardous material reference book and index. New York: van Nostrand Reinhold ed; 1991 (1333p).
3. Anonymous. Methyl mercaptan. In: Documentation of the threshold limit values and biological exposure indices. ACGIH ed; 2001 (2p).
4. Anonyme. Méthyl mercaptan. In: International chemical safety card. Genève: QMS; 1991 (2p).
5. Anonymous. Methyl mercaptan. Cincinnati: NIOSH ed; 1998 (6p).
6. Johnson PW, Ng W, Tonzetich J. Modulation of human gingival fibroblast cell metabolism by methyl mercaptan. J Periodontal Res 1992;27:476-83.
7. INRS (Institut National de la Recherche et de la Sécurité). http://www.inrs.fr.
8. Blanchette AR, Cooper AD. Determination of hydrogen sulfide and methyl mercaptan in mouth air at the parts-per-billion level by gas chromatography. Anal Chem 1976;48:729-31.
9. Jaeppinen P, Kangas J, Silakoski L, Savolainen H. Volatile metabolites in occupational exposure to organic sulfur compounds. Arch Toxicol 1993;67:104-6.
10. Wu HL, Funazo K, Tanaka M, Shono T. Derivatization-gas Chromatographic determination of mercaptans. Anal Lett 1981;14:1625-36.
11. Dowty B, Carlisle D, Laseter JL, Gonzalez PM. Gas Chromatographic mass spectrometric computer analysis of volatile components in blood plasma from hemodialysis patients. Biomed Mass Spectrom 1975;2:142-7.
12. Budavari S, O'Neil MJ, Smith A, Heckelman PE. The Merck index. Rahway: Merck and Co; 1989 (1606p).
13. Anonymous. Ethyl mercaptan. In: Noticias de seguridad. Consejo Interamericano de Seguridad; 1992 [54(6):5p].
14. Commission de la santé et de la sécurité au travail. Service du répertoire toxicologique (Québec, Canada). http//www.reptox.csst.qc.ca/Rechercheproduits.asp#resultats.
15. Ames RG, Stratton JW. Acute health effects from community exposure to N-propylmercaptan from an ethoprop (Mocap)-trzeated potato field in Siskiyou County, California (USA). Arch Environ Health 1991;46:213-7.
16. Anonymous. N-butyl mercaptan. Cincinnati: NIOSH ed; 1988 (6p).
17. Thomas WC, Seckar JA, Johnson JT, Ulrich CE, Klonne DR, Schardein JL, et al. Inhalation teratology studies of n-butyl mercaptan in rats and mice. Fund Appl Toxicol 1987;8:170-8.
18. Stein VB, Narang RS. Determination of mercaptans at microgram-per-cubic- meter levels in air by gas chromatography with photoionization detection. Anal Chem 1982;54:991-2.
19. Doizaki WM, Zieve L. An improved method for measuring blood mercaptans. J Lab Clin Med 1977;90:849-55.
20. BIBRA working group. N-dodecyl mercaptan. In: Toxicity profile. The British Industrial Biological Research Association ed; 1988 (4p).
21. EPA/OTS. Inhalation teratology study of T-dodecyl mercaptan in rats and mice with cover letter dated 061286. Doc#FYI-OTS-0686-0234.
22. Hazardous substances data bank, http://toxnet.nlm.nih.gov/cgi-bin/sis/ htmlgen? HSDB.
23. Anonymous. Phenyl mercaptan. In: Documentation of the threshold limit values and biological exposure indices. ACGIH ed; 2001 (2p).
24. Anonymous. Final report on the developmental toxicity of thiophenol (CAS no 108-98-5) in Sprague-Dawley (CD (Trade name)) rats on gestational days 6 through 15. Govt Reports Announcements and Index; 1994 (12p).
25. Anonyme. Perchlorométhyl mercaptan. In: International chemical safety card. Genève: QMS; 1991 (2p).
26. Althoff H. Fatal perchloromethyl mercaptan intoxication. Arch Toxikol 1973;31:121-35.
27. Anonymous. Perchloromethyl mercaptan. In: Documentation of the threshold limit values and biological exposure indices. ACGIH ed; 2001 (2p).
28. Anonymous. Methyl disulfide. In: EPA chemical profiles. Washington: USEPA ed; 1985 (4p).
29. BIBRA working group. Dimethyl sulphide. Toxicity profile. The British Industrial Biological Research Association ed; 1989 (6p).
30. Ljunggren G, Norberg B. On the effect and toxicity of dimethyl sulfide, dimethyl disulfide and methyl mercaptan. Acta Physiol Scand 1943;5:248-55.
31. WHO. International Program on Chemical Safety, http://www.inchem.org/ pages/search.html.
32. Le Bon AM, Roy C, Dupont C, Suschetet M. In vivo antigenotoxic effects of dietary allyl sulfides in the rat. Cancer Lett 1997;114:131-4.
33. Musk SR, Clapham P, Johnson IT. Cytotoxicity and genotoxicity of dially sulfide and diallyl disulfide towards Chinese hamster ovary cells. Food Chem Toxicol 1997;35:379-85.
34. Hadjiolov D, Fernando RC, Schmeiser HH, Wiessler M, Hadjiolov N, Pirajnov G. Effect of diallyl sulfide on aristolochic acid-induced forestomach carcinogenensis in rats. Carcinogenesis 1993;14:407-10.
35. Jang JJ, Ho KJ, Lee YS, Bae JH. Modifying responses of allyl sulfide, indole-2-carbinol and germanium in a rat multi-organ carcinogenensis model. Carcinogenesis 1991;12:691-6.
36. Singh A, Shukla Y. Antitumour activity of diallyl sulfide on polycyclic aroamtic hydrocarbon-induced mouse skin carcinogenesis. Cancer Lett 1998;131:209-14.
37. Chen GW, Chung JG, Hsieh CL, Lin JG. Effects of the garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in human colon tumour cells. Food Chem Toxicol 1998;36:761-70.
38. Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas: a clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992;128:775-80.
39. Eisenmenger W, Drasch G, Von Clarmann M, Kretschmer E, Roider G. Clinical and morphological findings on mustard gas (bis(2-chloroethyl)sulfide) poisoning. J Forensic Sci 1991;36:1688-98.
40. Gentilhomme E, Reano A, Pradel D, Bergier J, Schmitt D, Neveux Y. In vitro dermal intoxication by bis(chloroethyl) sulfide. Effect on secondary epidermization. Cell Biol Toxicol 1998;14:1-11.
41. Jaeger J, Schmid P. Vesicant studies. 2. Volatility determinations of butyl 2-chloroethyl sulfide on various surfaces including pig skin. Govt Reports Announcements and Index; 1987.
42. Tokuoka S, Hayashi Y, Inai K, Egawa H, Aoki Y, Akamizu H, et al. Early cancer and related lesions in the bronchial epithelium in former workers of mustard gas factory. Acta Pathol Jap 1986;36:533-42.
43. Steinhanses J, Schoene K. Thermal desorption-gas chromatography of some organnophosphates and S-mustard after trapping on Tenax. J Chromatogr 1990;514:273-8.
44. Fowler WK, Smith Jr. JE. Solid sorbent collection and gas Chromatographic determination of bis(2-chloroethyl) sulfide in air at trace concentrations. J Chromatogr Sci 1990;28:118-22.
45. Tomb RR, Lepoittevin JP, Caussade P. Contact allergy to 2-aminophenyl disulfide. Contact Dermatitis 1991;25:196-7.
46. Hegyi E. Hypersensitivity to Pneumax (2,2′-dibenzothiazyl disulfide) as a cause of occupational contact exzema in a miner with a group hypersensitivity to 2-mercapto-benzothiazole. Prac Lek 1990;42:436-7.
47. Anigbogu AM, Williams AC, Barry BW, Edwards HG. Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm 1995;125:265-82.
48. Ashton P, Walters KA, Brain KR, Hadgraft J. Surfactant effects in percutaneous absorption. Part 1. Effects on the transdermal flux of methyl nicotinate. Int J Pharm 1992;87:261-4.
49. Ghosh TK, Habib MJ, Childs K, Alexander M. Transdermal delivery of metoprolol. Part 1. Comparison between hairless mouse and human cadaver skin and effect of n-decylmethyl sulfoxide. Int J Pharm 1992;88:391-6.
50. Spruance SL, McKeough MB, Cardinal JR. Dimethyl sulfoxide as a vehicle for topical antiviral chemotherapy. Govt Reports Announcements and Index; 1981 (2).
51. Comas D, Mateu J. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion. Ann Pharmacother 1996;30:244-6.
52. Lawrence HJ, Goodnight SH. Dimethyl sulfoxide and extravasation of anthracycline agents. Ann Intern Med 1983;98:1025.
53. St Germain B, Houlihan N, D'Amato S. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations. J Intravein Nurs 1994;17:261-4.
54. Burgess JL, Hamner AP, Robertson WO. Sulfhemoglobinemia after dermal application of DMSO. Vet Hum Toxicol 1998;40:87-9.
55. Van Rijswijk MH, Donker AJ, Ruinen L. Dimethyl sulfoxide in amyloidosis. Lancet 1979;313:207-8.
56. Yellowlees P, Greenfield C, McIntyre N. Dimethylsulfoxide induced toxicity. Lancet 1980;316:1004-6.
57. Qian KN, Cai HJ, Chen SC, Liu YS. Study on new preparation of dimethyl sulfoxide injection for reducing intracranial pressure and its clinical application. Chin J Hosp Pharm 1990;10:116-8.
58. Muther RS, Bennett WM. Effects of dimethyl sulfoxide on renal function in man. JAMA 1980;244:2081-3.
59. Johnson PR, McKay KO, Armour CL, Black JL. The maintenance of functional activity in human isolated bronchus after cryopreservation. Pulm Pharmacol 1995;8:43-7.
60. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994;45:187-8.
61. Sato F, Saito H, Sugiuchi A, Hiroi M. Cryopreservation of various stage human embryos and pregnancies. Teratology 1990;42:48A.
62. Knudsen LE. In: Nordic expert group. Dimethylsulfoxide. Arbete och Halsa; 1991. p. 155-92.
63. Criteria group for occupational standards. In: Scientific basis for Swedish occupational standards. XIII. Consensus report for dimethylsulfoxide (DMSO). Arbete och Halsa; 1992. p. 26-31.
64. Bennett WM, Muther RS. Lack of nephrotoxicity of intraveinous dimethylsulfoxide. Clin Toxicol 1981;18:615-8.
65. Bond GR, Curry SC, Dahl DW. Dimethylsulphoxide induced encephalopathy. Lancet 1989;1:1134-5.
66. Shirley HH, Lundergan MK, Williams HJ, Spruance SL, Lack of ocular changes with dimethyl sulfoxide therapy of scleroderma. Pharmacotherapy 1989;9:165-8.
67. Mehta AC, Peaker S, Acomb C, Calvert RT. Rapid gas chromatographic determination of dimethyl sulfoxide and its metabolite dimethyl sulfone in plasma and urine. J Cnromatogr 1986;383:400-4.
68. Terazawa K, Kaji H, Akabane H, Takatori T. Determination of DMSO in blood and adipose tissue by headspace gas analysis. J Chromatogr Biomed Appl 1991;565:453-6.
69. Emmett EA, Risby TH, Taylor J, Chen CL, Jiang L, Feinman SE. Skin elicitation threshold of ethylbutyl thiourea and mercaptobenzothiazole with relative leaching from sensitizing products. Contact Dermatitis 1994;30:85-90.
70. Reepmeyer JC, Juhl YH. Contamination of injectable solutions with 2-mercaptobenzothiazole leached from rubber closures. J Pharm Sci 1983;75:1302-5.
71. Hanssen HW, Henderson ND. Review of the environmental impact and toxic effects of 2-MBT. Govt Reports Announcements and Index; 1993.
72. Anonymous. 2-mercaptobenzothiazole. Beratergremium für umweltrelevante Altstoffe (BUA; 1997 (183p).
73. Anonymous. 2-mercaptobenzothiazol. Toxikologische Bewertung, Heidelberg: Berufgenossenschaft der chemischen Industrie; 2000 (143p).
74. Feinman SE. Sensitivity to rubber chemicals. J Toxicol Cutan Ocul Toxicol 1987;6:117-53.
75. Riordan AT, Nahass GT. Occupational vitiligo following allergic contact dermatitis. Contact Dermatitis 1996;34:371-2.
76. BIBRA working group. 2-mercaptobenzothiazole and its sodium salt. In: Toxicity profile. The British Industrial Biological Research Association ed; 1990 (7p).
77. Manninen A, Auriola S, Vartiainen M, Liesivuroi J, Turunen T, Pasanen M. Determination of urinary 2-mercaptobenzothiazole (2-MBT), the mainmetabolite of 2-(thiocyanomethylthio)benzothiazole (TCMTB) in humans and rats. Arch Toxicol 1996;70:579-84.
78. Airaudo CB, Gayte-Sorbier A, Momburg R, Laurent P. Thin-layer Chromatographic characterization of benzothiazole derivatives and beta-sitosterol leached by disposable syringes. J Chromatogr 1986;354:341-54.
79. Anonymous. 2,2′-dithio-bis-benzothiazole, Beratergremium für umweltrelevante Altstoffe (BUA; 1995 (71p).
80. Scansetti G. Toxic agents emitted from office machines and materials. In: Ergonomics and health in modern offices. London: Taylor and Francis; 1984. p. 1-18.
81. Zina AM, Bedello PG, Cane D, Bundino S, Benedetto A. Dermatitis in a rubber tyre factory. Contact Dermatitis 1987;17:17-20.
82. Anonyme. Benzothiazol-2-thiol. In: International chemical safety card. Genève: QMS; 1991 (2p).
83. Anonymous. 2-mercaptobenzimidazol. Toxikologische Bewertung. Heidelberg: Berufgenossenschaft der chemischen Industrie; 2000 (51p).
84. Lefebvre PA, Tinwell, Ashby J. Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacl) rats: consideration of a reduced mutation assay protocol. Mutagenesis 1997;12:45-7.
85. Meek JH, Pettit BR. Avoidable accumulation of potentially toxic levels of benzothiazoles in babies receiving intraveinous therapy. Lancet 1985;2:1090-2.
86. Cézard C, Haguenoer JM. Sulfures de carbone. Encycl Méd Chir (Elsevier SAS, Paris), Toxicologie, 16-058-V-10, 1991:(10p).
87. Herlofson BB, Barkvoll P. Oral mucosal desquamation caused by two toothpaste detergents in an experimental model. Eur J Oral Sci 1996;104:21-6.
88. Lower ES. Sodium and other lauryl sulfates. Part 2. Manuf Chem 1983;54:63-4.
89. Anonymous. RED facts: lauryl sulfate salts. Govt Reports Announcements and Index; 1994.
90. Patil S, Singh P, Sarasour K, Maibach H. Quantification of sodium lauryl sulfate penetration into the skin and underlying tissues after topical application: pharmacological and toxicological implications. J Pharm Sci 1995;84:1240-4.
91. Berenson MM, Temple AR. Detergent toxicity: effects on oesophageal and gastric mucosa. Clin Toxicol 1975;8:399-404.
92. Anonymous. Final report on the safety assessment of sodium lauryl sulfate and ammonium lauryl sulfate. J Am Coll Toxicol 1983;2:127-81.
93. Freeman S, Maibach H. Study of irritant contact dermatitis produced by repeat patch-test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss and laser doppler velocimetry. J Am Accad Dermatol 1988;19:496-502.
94. Willis CM, Stephens CJ, Wilkinson JD. Epidermal damage induced by irritants in man: a light and electron microdscopic study. J Invest Dermatol 1989;93:695-9.
95. Cua AB, Wilhelm KP, Maibach HI. Cutaneous sodium lauryl sulfate irritation potential: age and regional variability. Br J Dermatol 1990;123:607-14.
96. Bjornberg A. Increased skin reactivity to primary irritants provoked by hand eczema. Arch Dermatol Forsch 1974;249:189-400.
97. Agner T. Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulfate. Acta Derm Venereal 1991;71:296-300.
98. Seidenari S, Belletti B, Schiavi ME. Skin reactivity to sodium lauryl sulfate in patients with respiratory atopy. J Am Acad Dermatol 1996;35:47-52.
99. McLelland J, Shuster S, Matthews JN. Irritants increase the response to an allergen in allergic contact dermatitis. Arch Dermatol 1991;127:1016-9.
100. Campiglio R, Brambilla G, Briatico Vangosa G, De Micheli P, Nava C. Aspects of allergic disease in the cosmetics industry. Med Lav 1984;75:407-11.
101. Kolmark G. Mutagenic properties of certain esters of inorganic acids investigates by the Neurospora back-mutation test. In: Comptes-rendus des travaux du laboratoire Carlsberg, série physiologique, 1956. p. 205-20 (26).
102. Ogata M, Yamasaki Y, Kawai T. Significance of urinary phenyl sulfate and phenyl glucuronide as indices of exposure to phenol. Int Arch Occup Environ Health 1986;58:197-202.
103. Pierce Jr. WM, Nerland DE. Qualitative and quantitative analyses of phenol, phenylglucuronide and phenylsulfate in urine and plasma by gas chromatography mass spectrometry. J Anal Toxicol 1988;12:344-7.
104. Anonymous. Ammonium lauryl sulfate. In: Chemical safety information sheet. Hamilton: Canadian Centre for Occupational Health and Safety ed; 1990 (1p).
105. Anonyme. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans: some anti-thyroïd and related substances, nitrofurans and industrial chemicals. Thiourea 1974;7:95-109.
106. Anonyme. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some thyrotropic agents. Thiourea 2001;79:703-25.
107. Kanerva L, Estlander T, Jolanki R. Occupational allergic contact dermatitis caused by thiourea compounds. Contact Dermatitis 1994;31:242-8.
108. Dooms-Goossens A, Debusschere K, Morren MR, Coopman S. Silver polish: another source of contact dermatitis reactions to thiourea. Contact Dermatitis 1988;19:133-5.
109. Dutch Expert Committee for Occupational Standards. Health-based recommended occupational exposure for thiourea. Directorate General of Labour; 1990 (11p).
110. Criteria Group for Occupational Standards. In: Scientific basis for Swedish occupational standards. XX. Consensus report for thiourea. Arbete och Halsa; 1999. p. 97-109.
111. Anonyme. Thiourea. New Jersey Department of Health. Right-to-know Program; 1996 (6p).
112. Dooms-Goossens A, Chrispeels MT, De Veyler H, Roelandts R, Willems L, Degreef H. Contact and photocontact sensitivity problems associated with thiourea and its derivatives: a review of the literature and case reports. Br J Dermatol 1987;116:573-9.
113. Bruze M, Fregert S. Allergic contact dermatitis from ethylene thiourea. Contact Dermatitis 1983;9:208-12.
114. Roberts JL, Hanifin JM. Athletic shoe dermatitis: contact allergy to ethyl butyl thiourea. JAMA 1979;241:275-6.
115. Andersen KE. Diethylthiourea contact dermatitis from an acidic detergent. Contact Dermatitis 1983;9:146.
116. Masmoudi ML, Lachapelle JM. Occupational dermatitis to dihydroxydiphenyl and diphenylthiourea in neoprene gloves. Contact Dermatitis 1987;16:290-1.
117. Meding B, Baum H, Bruze M, Roupe G, Trulsson L. Allergic contact dermatitis from diphenylthiourea in Vulkan heat retainers. Contact Dermatitis 1990;22:8-12.
118. Kanerva L, Jolanki R, Plosila M, Estlander T. Contact dermatitis from dibutylthiourea. Report of a case with fine structural observations of epicutaneous testing with dibutylthiourea. Contact Dermatitis 1984;10:158-62.
119. Schmid-Grendelmeier P, Elsner P. Contact dermatitis due to occupational dibutylthiourea exposure: a case of phone-card dermatitis. Contact Dermatitis 1995;32:308-9.
120. Anonyme. Current Intelligence Bulletin no 22: ethylene thiourea. Cincinnati: NIOSH ed; 1978 (11p).
121. Smith DM. Ethylene thiourea: thyroïde function in two groups of exposed workers, Br J Ind Med 1984;41:362-6.
122. Lembo S, Marzillo G, Sgambati C. Gas-liquid Chromatographic method for determining propylenthiourea in rat tissues and fluids. J Chromatogr 1983;267:427-30.
123. Volden G. Peripheral neuropathy: side effects of sulfones. BMJ 1977;1:1193.
124. Mayer K. ley AB. Hemolysis of red cells due to sulfone. Ann Intern Med 1970;72:711-4.
125. Zlatkis A, Liebich HM. Profile of volatile metabolites in human urine. Clin Chem 1971;17:592-4.
126. Ogata M, Fujii T. Quantitative determination of urinary dimethyl sulfoxide and dimethyl sulfone by the gas chromatograp equipped with a flame photometric detector. Ind Health 1979;17:73-8.
127. Clark AJ. Determination of organosulfure compounds and amino acid-mustard conjugates by liquid chromatography with amperometric detection. Anal Proc 1993;30:355-7.
128. Thio-urées : http:monographs.iarc.fr/htdocs/monographs/volo7/ thiourea.html.
129. Monographies du Centre international de recherche sur le cancer : http://monographs.iarc.fr et http://iarc.fr.
130. National Toxicology program : http:ntp.niehs.nih.gov/.
131. National Institute for Occupational Safety and Health (NIOSH). http://www.cdc.gov/niosh/database.html
132. Site en français : Programme international sur la sécurité des substances chimiques (International Chemical Safety Cards) : http:www.cdc.gov.niosh/ipcs/French.html.